Skip to content

What’s Happening in the Month Ahead: February 2018

What's Happening in the Month Ahead: February 2018

Clinical Trial Updates Due at Angiogenesis Meeting

Investigators will present a host of updates on clinical trials in retina at Angiogenesis, Exudation and Degeneration 2018 on Saturday, February 10, in Miami. Bascom Palmer Eye Institute at the University of Miami is host. Among the clinical trials that presenters will discuss: one-year data from the Proxima A trial of geographic atrophy with no intervention; initial results of a Phase Ib trial of HMR59 gene therapy (Hemera Biosciences) for dry age-related macular degeneration (AMD); a Phase I/II study of carotuximab (DE-122, Tracon Pharmaceuticals), an endoglin antibody, for refractory wet AMD; top-line Phase III results of brolucizumab (Novartis) anti-VEGF treatment for retinal disease; and the BOULEVARD Phase II trial of the anti-VEGF/anti-angiopoietin bispecific antibody RG7716 (Roche) for treatment of diabetic macular edema.

Roche ‘Virtual Pipeline’ Event

Roche will also hold a virtual pipeline event Tuesday, February 13, in which Sascha Fauser, MD, head pRED ophthalmology, will discuss the BOULEVARD Phase II trial. Jason Ehrlich, MD, PhD, senior group medical director, ophthalmology, will also present an ophthalmology overview.

Allergan at Leerink Partners Conference

Allergan has a busy month ahead. First, the company is set to report its 2017 results on Tuesday, February 6. Then on Thursday, February 15, two Allergan executives – chief commercial officer William Meury and chief R&D officer David Nicholson – will present at the Leerink Partners Seventh Annual Global Healthcare Conference in New York. The presentation will be webcast live and can be accessed at Allergan’s investor relations page or at http://wsw.com/webcast/leerink30/agn/.

Big Month for Earnings Reports

February will be a big month for other earnings reports. pSivida Corp. will report results for its second quarter of fiscal year 2018 on Wednesday, February 7. Management will host a conference call to review the results at 4:30 p.m. EST on the same day. A link to the live webcast will be available on the company’s website.

And, as its stock traded at a one-year low, Regeneron Pharmaceuticals is slated to report earnings on Thursday, February 8. The company will host a conference call and simultaneous webcast at 8:30 a.m. EST that day. A link to the conference call will be available on the company’s website.

SHARE THIS ARTICLE WITH YOUR COLLEAGUES:

RECOMMENDED FOR YOU

Eyeing Gene Therapy’s Ocular Future

Eyeing Gene Therapy’s Ocular Future

OIS Index Deep in Bear Territory in Q3

OIS Index Deep in Bear Territory in Q3

Retina Treatment Beyond Protocol

Retina Treatment Beyond Protocol

What Has 50 Companies, Four Breakout Sessions, Winning Pitch Winners, and a Keynote Conversation? OIS@AAO 2019

What Has 50 Companies, Four Breakout Sessions, Winning Pitch Winners, and a Keynote Conversation? OIS@AAO 2019

Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

5 Factors for Evaluating Investments in the Retina Space

5 Factors for Evaluating Investments in the Retina Space

About The Author

Rich Kirkner

Richard Kirkner is an award-winning journalist and editorial consultant who has specialized in ophthalmology and eye care media for three decades. Based in Philadelphia, his work has been recognized with more than 40 awards for editorial excellence.

SUBSCRIBE TO OUR NEWSLETTER

Get The Latest News In Opthalmologic Innovation To Your Inbox.

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.
Scroll To Top